← Leaderboards
Qi L Lu
Carolinas Medical Center
$2,662,437
Attributed
$2,662,437
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2M · FY2009–19$2.5M$1.9M$1.3M$625K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$4,704,845 · 4
By mechanism
U01$4,084,816 · 2
R61$378,291 · 1
P50$241,738 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Mutation”
- Richard A Gibbs · Baylor College Of Medicine$276,143,183
- David Heimbrook · Leidos Biomedical Research, Inc.$175,834,894
- Randall J Bateman · Washington University$154,391,630
- Eric Martin McDade · Washington University$96,219,353
- Stacey Gabriel · Massachusetts Institute Of Technology$95,141,374
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$93,475,056
Research focus
MutationMuscular DystrophiesGenesReporterMediatingPharmaceutical PreparationsMuscleIn VitroAnimal ModelMuscular Dystrophy, DuchenneBirthAffectCell Culture TechniquesMaleDrug KineticsAntisense OligonucleotidesInvestigational TherapiesClinicDystrophinExonsLifeClinical TrialsMyoblastsRestoration
Grant awards (10)
Preclinic dose and delivery regime optimization and long-term efficacy evaluation of ribitol treatment for FKRP related dystroglycanopathy$378,291
R61 · FY2019 · NS · contact PI
Antisense therapy for DMD-Optimization and toxicology of AON for exon 45 skipping$1
U01 · FY2014 · NS · contact PI
Antisense therapy for DMD-Optimization and toxicology of AON for exon 45 skipping$1
U01 · FY2014 · NS · contact PI
Antisense therapy for DMD-Optimization and toxicology of AON for exon 45 skipping$1,013,015
U01 · FY2013 · NS · contact PI
Antisense therapy for DMD-Optimization and toxicology of AON for exon 45 skipping$1,013,015
U01 · FY2013 · NS · contact PI
Optimization of AO drugs 45, 51 & 53$241,738
P50 · FY2011 · AR · contact PI
Antisense therapy for DMD-Optimization and toxicology of AON for exon 45 skipping$540,575
U01 · FY2010 · NS · contact PI
Antisense therapy for DMD-Optimization and toxicology of AON for exon 45 skipping$540,575
U01 · FY2010 · NS · contact PI
Antisense therapy for DMD-Optimization and toxicology of AON for exon 45 skipping$488,817
U01 · FY2009 · NS · contact PI
Antisense therapy for DMD-Optimization and toxicology of AON for exon 45 skipping$488,817
U01 · FY2009 · NS · contact PI